A new way to study brain dynamics, drugs, and disease

Michael R. Tadross, MD, PhD

Machael Tadross

Thursday October 11 12:00 - 1:00PM

Add To Calendar

Fitzpatrick Center for Interdisciplinary Engineering, Medicine and Applied Sciences, Science Drive, Durham, NC, USA
Fitzpatrick CIEMAS 2240

About This Event:

Michael Tadross is an assistant professor of Biomedical Engineering at Duke University, where he develops genetically encoded technologies to target clinical drugs to specific cell types in the brain. He applies these methods to mouse models of neuropsychiatric disease to determine which brain cell types are responsible for beneficial vs harmful effects, providing a roadmap for development of next-generation targeted therapeutics. He received his BS degree in electrical and computer engineering at Rutgers University, an MD/PhD degree in biomedical engineering at the Johns Hopkins School of Medicine, completed postdoctoral study in cellular neuroscience at Stanford University, and began his independent research program as a Fellow at the HHMI Janelia Research Campus.

Sponsors:

  • School of Medicine (SOM)
  • Pratt School of Engineering
  • Duke Center for Applied Genomics and Precision Medicine

Learn more about DIBS

The Duke Institute for Brain Sciences is a scientific institute with a collaborative spirit and a commitment to education, service and knowledge across disciplines. We encourage creativity, taking risks, sharing ideas and working together.

eNewsletter

Sign up to receive email updates about DIBS news, events and more.

Subscribe